Valuation : UCB

Market Cap 39.2B 45.5B 37.12B 33.64B 63.12B 4,347B 63.44B 441B 170B 2,211B 171B 167B 6,988B P/E 2026 *
20.5x
P/E 2027 * 16.9x
Enterprise Value 39.51B 45.85B 37.41B 33.91B 63.61B 4,380B 63.93B 444B 171B 2,229B 172B 168B 7,042B EV / Sales 2026 *
4.54x
EV / Sales 2027 * 3.86x
Free-Float
61.59%
Yield 2026 *
0.71%
Yield 2027 * 0.73%
1 day+1.93%
1 week-2.37%
Current month-4.51%
1 month-9.11%
3 months-24.13%
6 months-18.99%
Current year-13.83%
1 week 200.7
Extreme 200.7
213.7
1 month 200.7
Extreme 200.7
226.2
Current year 200.7
Extreme 200.7
289.5
1 year 191.2
Extreme 191.2
289.5
3 years 65.4
Extreme 65.4
289.5
5 years 65.4
Extreme 65.4
289.5
10 years 54.84
Extreme 54.84
289.5
Manager TitleAgeSince
Chief Executive Officer 67 01/01/2015
Director of Finance/CFO 60 01/07/2020
Chief Tech/Sci/R&D Officer 59 01/05/2024
Director TitleAgeSince
Director/Board Member 55 01/01/2012
Director/Board Member 67 01/01/2015
Director/Board Member 56 24/04/2014
Date Insider Type Main position Quantity % Market Cap. Importance
15/1/26 Exercice

Executive/Senior Manager

3,000 0.0015%
15/1/26 Exercice

Executive/Senior Manager

3,000 0.0015%
15/1/26 Buy

Director

500 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+1.93%-2.37%-2.00%+149.45% 45.5B
-1.48%-5.59%+37.54%-6.24% 78.02B
-1.42%-4.24%-18.81%-37.78% 57.4B
+5.38%-1.09%+467.03%+36.08% 57.48B
-0.56%-2.21%-11.17%+25.38% 48.81B
+0.80%-1.67%+45.89%-16.13% 32.08B
-1.47%-4.17%+40.97%+88.59% 24.62B
-0.85%-8.64%-3.66%+144.26% 20.77B
-0.09%-3.61%+63.58%+97.66% 15.75B
-3.25%-7.11%-26.34%+571.29% 13.92B
Average -0.10%-4.12%+59.30%+105.25% 39.43B
Weighted average by Cap. +0.25%-3.80%+78.86%+54.79%

Financials

2026 *2027 *
Net sales 8.69B 10.09B 8.23B 7.46B 14B 964B 14.07B 97.78B 37.6B 490B 37.9B 37.07B 1,550B 9.68B 11.23B 9.16B 8.3B 15.58B 1,073B 15.66B 109B 41.85B 546B 42.18B 41.25B 1,725B
Net income 1.93B 2.24B 1.83B 1.66B 3.11B 214B 3.13B 21.72B 8.35B 109B 8.42B 8.23B 344B 2.32B 2.7B 2.2B 2B 3.74B 258B 3.76B 26.14B 10.05B 131B 10.13B 9.91B 414B
Net Debt 306M 355M 289M 262M 492M 33.88B 494M 3.44B 1.32B 17.23B 1.33B 1.3B 54.46B -1.81B -2.1B -1.71B -1.55B -2.91B -200B -2.93B -20.33B -7.82B -102B -7.88B -7.71B -322B
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
9,000
Date Price Change Volume
11/09/26 EUR 205.60 +1.93% 247,334
10/09/26 EUR 201.70 -1.42% 281,532
09/09/26 EUR 204.60 -1.11% 262,195
08/09/26 EUR 206.90 -1.62% 217,397
07/09/26 EUR 210.30 -0.14% 117,305
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
205.60EUR
Average target price
285.00EUR
Spread / Average Target
+38.62%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!